©The Author(s) 2026.
World J Gastroenterol. Jan 21, 2026; 32(3): 113935
Published online Jan 21, 2026. doi: 10.3748/wjg.v32.i3.113935
Published online Jan 21, 2026. doi: 10.3748/wjg.v32.i3.113935
Figure 1 Human liver transplantation peptides expression profile.
A: Schematic diagram of liver specimens sent to liquid chromatography-tandem mass spectrometry before and after transplantation in liver transplant patients; B: The heat map indicates the peptide profiles with significant differences between the indicated groups; C: The number of upregulation and downregulation differentially expressed endogenous peptides from liver transplant patients compared with pretransplant; D: This volcano plot represents the distribution of upregulation and downregulation peptides; E-G: Distribution of the length, molecular weight and isoelectric point of peptides; H: Correlation between molecular weight and isoelectric point distribution of peptides. MW: Molecular weight; pI: Isoelectric point; LC/MS-MS: Liquid chromatography-tandem mass spectrometry.
- Citation: Xie HW, Bao Q, Chen ZX, Zhang XM, Liu XY, Wang R, Cai YS, Sun P. Targeting Jun N-terminal kinase phosphorylation: A human-derived hepatoprotective peptide human liver transplantation peptide 1 attenuates hepatic ischemia-reperfusion injury. World J Gastroenterol 2026; 32(3): 113935
- URL: https://www.wjgnet.com/1007-9327/full/v32/i3/113935.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i3.113935